Adjuvant chemotherapy decision-making in stage II colon adenocarcinoma associated with patients' age and high-risk factors.

Pengwen Zheng Chao Ye Hui Liu Xin-Yi Gao Hai Huang

Published in: International journal of colorectal disease (2023)

Age and HRFs could be preferable for determining the group of stage II colon adenocarcinoma patients who would benefit from AC. Patients aged < 50 years with two or more HRFs might be a potential benefit population for AC.

Keyphrases

end stage renal disease
risk factors
ejection fraction
newly diagnosed
chronic kidney disease
squamous cell carcinoma
peritoneal dialysis
prognostic factors
radiation therapy